Orchid Pharma Limited (ORCHPHARMA) — Financial Results
Orchid Pharma announced that its trading window will close on July 1, 2026, ahead of the unaudited limited reviewed financial results for Q1 FY2026-27 ending June 30, 2026, as required by SEBI insider trading regulations.
About Orchid Pharma Limited (ORCHPHARMA)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
📡 Get AI alerts when ORCHPHARMA files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track ORCHPHARMA — Free💡 Ask AI about this filing
📊 More ORCHPHARMA filings
- share transfer — 11 July 2026 Orchid Pharma confirmed compliance with SEBI Depositories and Participants Regulations 2018 for Q1 F...
- 🔴 Corporate Action — 12 June 2026 Orchid Pharma announced NCLT approval of its amalgamation with Dhanuka Laboratories, effective April...
- Announcement — 11 June 2026 Orchid Pharma disclosed a GST department order demanding Rs. 1.67 crores plus interest for a pre-acq...
- 🔴 Corporate Action — 5 June 2026 Orchid Pharma announced that the National Company Law Tribunal approved the merger of Dhanuka Labora...
- 🔴 Financial Results — 1 June 2026 Orchid Pharma reported Q4 FY26 revenue of **₹238 crores** and FY26 revenue of **₹811 crores**, with ...
🔥 Also filed on 26 June 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
📡 Get AI alerts when ORCHPHARMA files new disclosures
Track ORCHPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track ORCHPHARMA — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research